We are live on ! Find out more
PWP

Private Wealth Partners Portfolio holdings

AUM $1.3B
1-Year Est. Return 26.2%
This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+26.2%
3 Year Est. Return
+92.82%
5 Year Est. Return
+128.24%
10 Year Est. Return
+552.95%
AUM
$642M
AUM Growth
-$7.14M
Cap. Flow
-$12M
Cap. Flow %
-1.88%
Top 10 Hldgs %
46.71%
Holding
142
New
8
Increased
39
Reduced
47
Closed
19

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$4.86M
2
ZTS icon
Zoetis
ZTS
+$2.49M
3
BABA icon
Alibaba
BABA
+$2.06M
4
GS icon
Goldman Sachs
GS
+$1.75M
5
AXP icon
American Express
AXP
+$1.34M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.88M
2
FNV icon
Franco-Nevada
FNV
+$5.44M
3
SCHW
Charles Schwab
SCHW
+$3.67M
4
EOG icon
EOG Resources
EOG
+$3.34M
5
FRC
First Republic Bank
FRC
+$1.54M

Sector Composition

Rank Sector Weight
1 Financials 21.34%
2 Healthcare 20.87%
3 Technology 18.4%
4 Communication Services 14.03%
5 Consumer Discretionary 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGLD icon
101
Royal Gold
RGLD
$17.1B
$271K 0.04%
2,200
-3,000
-58% -$365K
NVS icon
102
Novartis
NVS
$295B
$267K 0.04%
3,069
-1,500
-33% -$135K
ET icon
103
Energy Transfer Partners
ET
$70.1B
$264K 0.04%
20,200
– –
IBM icon
104
IBM
IBM
$202B
$262K 0.04%
1,883
-418
-18% -$56.4K
PM icon
105
Philip Morris
PM
$301B
$260K 0.04%
+3,420
New +$271K
IRDM icon
106
Iridium Communications
IRDM
$4.85B
$255K 0.04%
12,000
– –
IJH icon
107
iShares Core S&P Mid-Cap ETF
IJH
$123B
$253K 0.04%
6,545
-70
-1% -$2.69K
UN
108
DELISTED
Unilever NV New York Registry Shares
UN
$240K 0.04%
4,000
– –
ABBV icon
109
AbbVie
ABBV
$458B
$239K 0.04%
3,150
-2,100
-40% -$144K
ENB icon
110
Enbridge
ENB
$124B
$234K 0.04%
6,666
– –
TXN icon
111
Texas Instruments
TXN
$255B
$232K 0.04%
1,792
– –
LLY icon
112
Eli Lilly
LLY
$1.07T
$231K 0.04%
+2,069
New +$230K
CHTR icon
113
Charter Communications
CHTR
$14.7B
$226K 0.04%
549
-1,700
-76% -$686K
IWM icon
114
iShares Russell 2000 ETF
IWM
$80.9B
$214K 0.03%
1,411
– –
IMDX
115
Insight Molecular Diagnostics
IMDX
$153M
$168K 0.03%
+4,000
New +$157K
FWONK icon
116
Liberty Media Series C
FWONK
$24.3B
$14K ﹤0.01%
341
-11,377
-97% -$442K
LBTYK icon
117
Liberty Global Class C
LBTYK
$3.27B
$13K ﹤0.01%
551
-22,000
-98% -$573K
ALGN icon
118
PUT
Align Technology
ALGN
$12B
$5K ﹤0.01%
5,500
– –
MSFT icon
119
PUT
Microsoft
MSFT
$2.84T
$5K ﹤0.01%
+6,200
New +$853K
PFE icon
120
PUT
Pfizer
PFE
$140B
$5K ﹤0.01%
6,640
– –
SCHW
121
PUT
Charles Schwab
SCHW
$177B
$2K ﹤0.01%
+7,000
New +$283K
BMY icon
122
PUT
Bristol-Myers Squibb
BMY
$127B
$1K ﹤0.01%
7,500
– –
PG icon
123
PUT
Procter & Gamble
PG
$343B
$1K ﹤0.01%
+3,400
New +$402K
AWK icon
124
PUT
American Water Works
AWK
$26.3B
– –
-5,400
Closed -$4K
AXP icon
125
PUT
American Express
AXP
$223B
– –
-2,600
Closed -$2K
2 3 4
5
6

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PR
Payden & Rygel Los Angeles, California $1.3B AUM 28.32% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Private Wealth Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Private Wealth Partners held 142 positions worth $642M, down 1.1% from $650M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Private Wealth Partners's Q3 2019 filing shows 8 new, 39 increased, 47 reduced and 19 closed positions. Its largest new stake was Principia Biopharma Inc. Common Stock: 24,000 shares worth $678K. The largest sale was Pfizer, an estimated $6.88M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.

  • Private Wealth Partners's largest Q3 2019 buy was Principia Biopharma Inc. Common Stock: 24,000 shares worth $678K.
  • Private Wealth Partners added most to AT&T in Q3 2019, an estimated $4.86M increase.
  • Private Wealth Partners's biggest Q3 2019 reduction was Pfizer, cutting an estimated $6.88M.
  • Private Wealth Partners fully exited Franco-Nevada in Q3 2019, selling an estimated $5.44M.
  • Private Wealth Partners's ten largest holdings make up 47% of its $642M portfolio in Q3 2019.
  • Private Wealth Partners opened 8 new positions and closed 19 in Q3 2019.
  • Private Wealth Partners's portfolio value fell 1.1% quarter-over-quarter to $642M.

Based on Private Wealth Partners's 13F filing for Q3 2019, filed 12 Nov 2019.